Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Bronchodilator Agents"" wg kryterium: Temat


Tytuł :
Evidence-based treatment during the SARS-CoV-2 pandemic: Identifying the knowns and unknowns of nebulization.
Autorzy :
Woods JA
Pokaż więcej
Źródło :
Journal of the American Pharmacists Association : JAPhA [J Am Pharm Assoc (2003)] 2021 Mar-Apr; Vol. 61 (2), pp. e55-e56. Date of Electronic Publication: 2020 Sep 30.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
SARS-CoV-2*
Asthma/*drug therapy
Bronchodilator Agents/*therapeutic use
COVID-19/*drug therapy
Asthma/complications ; Bronchodilator Agents/administration & dosage ; Bronchodilator Agents/adverse effects ; COVID-19/complications ; COVID-19/transmission ; Evidence-Based Medicine ; Humans ; Nebulizers and Vaporizers ; Pandemics
Czasopismo naukowe
Tytuł :
A Randomized Trial of Comparing a Combination of Montelukast and Budesonide With Budesonide in Allergic Rhinitis.
Autorzy :
Chen H; Department of Otolaryngology-Head and Neck Surgery.; and Department of Allergy, Beijing TongRen Hospital, Capital Medical University, Beijing, China.; Beijing Key Laboratory of Nasal Diseases, Beijing Institute of Otolaryngology, Beijing, China.; Department of Otolaryngology, Wangjing Hospital, China Academy of Chinese Medical Science, Beijing, China.
Zhang L; Department of Otolaryngology-Head and Neck Surgery.; and Department of Allergy, Beijing TongRen Hospital, Capital Medical University, Beijing, China.; Beijing Key Laboratory of Nasal Diseases, Beijing Institute of Otolaryngology, Beijing, China.
Lou H; Department of Otolaryngology-Head and Neck Surgery.; Beijing Key Laboratory of Nasal Diseases, Beijing Institute of Otolaryngology, Beijing, China.
Wang Y
Cao F; and Department of Allergy, Beijing TongRen Hospital, Capital Medical University, Beijing, China.; Beijing Key Laboratory of Nasal Diseases, Beijing Institute of Otolaryngology, Beijing, China.
Wang C; Department of Otolaryngology-Head and Neck Surgery.; and Department of Allergy, Beijing TongRen Hospital, Capital Medical University, Beijing, China.; Beijing Key Laboratory of Nasal Diseases, Beijing Institute of Otolaryngology, Beijing, China.
Pokaż więcej
Źródło :
The Laryngoscope [Laryngoscope] 2021 Apr; Vol. 131 (4), pp. E1054-E1061. Date of Electronic Publication: 2019 Nov 29.
Typ publikacji :
Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Acetates/*therapeutic use
Bronchodilator Agents/*therapeutic use
Budesonide/*therapeutic use
Cyclopropanes/*therapeutic use
Leukotriene Antagonists/*therapeutic use
Quinolines/*therapeutic use
Rhinitis, Allergic/*drug therapy
Sulfides/*therapeutic use
Acetates/administration & dosage ; Administration, Intranasal ; Adult ; Bronchodilator Agents/administration & dosage ; Budesonide/administration & dosage ; China ; Cyclopropanes/administration & dosage ; Drug Therapy, Combination ; Female ; Humans ; Leukotriene Antagonists/administration & dosage ; Male ; Nasal Obstruction/drug therapy ; Quinolines/administration & dosage ; Sulfides/administration & dosage
Czasopismo naukowe
Tytuł :
Factors Determining Continuous Infusion Aerosol Delivery During Mechanical Ventilation.
Autorzy :
McPeck M; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Stony Brook University Medical Center, Stony Brook, New York. .
Ashraf S; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Stony Brook University Medical Center, Stony Brook, New York.
Cuccia AD; Respiratory Care Program, School of Health Technology and Management, Stony Brook University, Stony Brook, New York.
Smaldone GC; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Stony Brook University Medical Center, Stony Brook, New York.
Pokaż więcej
Źródło :
Respiratory care [Respir Care] 2021 Apr; Vol. 66 (4), pp. 573-581. Date of Electronic Publication: 2020 Sep 23.
Typ publikacji :
Journal Article
MeSH Terms :
Bronchodilator Agents*
Respiration, Artificial*
Administration, Inhalation ; Adult ; Aerosols ; Albuterol ; Drug Delivery Systems ; Equipment Design ; Humans ; Nebulizers and Vaporizers ; Reproducibility of Results
Czasopismo naukowe
Tytuł :
The impact of changing patient interfaces on delivering aerosol with titrated oxygen in the high flow system.
Autorzy :
Madney YM; Department of Clinical Pharmacy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt.
Ibrahim Laz N; Department of Chest Diseases, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt.
Elberry AA; Department of Clinical Pharmacology, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt.
Rabea H; Department of Clinical Pharmacy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt.
Abdelrahim MEA; Department of Clinical Pharmacy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt.
Pokaż więcej
Źródło :
International journal of clinical practice [Int J Clin Pract] 2021 Apr; Vol. 75 (4), pp. e13898. Date of Electronic Publication: 2020 Dec 19.
Typ publikacji :
Journal Article
MeSH Terms :
Bronchodilator Agents*
Oxygen*
Administration, Inhalation ; Aerosols ; Albuterol ; Equipment Design ; Humans ; Nebulizers and Vaporizers
Czasopismo naukowe
Tytuł :
It is high time for the scholarly societies to standardize the bronchodilator responsiveness in children.
Autorzy :
Saad HB; Heart Failure (LR12SP09) Research Laboratory, Farhat HACHED Hospital of Sousse, University of Sousse, Sousse, Tunisia; .
Pokaż więcej
Źródło :
Allergologia et immunopathologia [Allergol Immunopathol (Madr)] 2021 Mar 01; Vol. 49 (2), pp. 225-227. Date of Electronic Publication: 2021 Mar 01 (Print Publication: 2021).
Typ publikacji :
Letter; Comment
MeSH Terms :
Asthma*/drug therapy
Bronchodilator Agents*/therapeutic use
Albuterol/therapeutic use ; Child ; Humans ; Methacholine Chloride ; Nitric Oxide ; Spirometry
Opinia redakcyjna
Tytuł :
Differentiation of Tarchonanthus camphoratus L. and Tarchonanthus parvicapitulatus P.P.J. Herman (Asteraceae) using electron microscopy, and comparison of their biological activities.
Autorzy :
Aro AO; Department of Agriculture and Animal Health, Faculty of Agriculture and Environmental Sciences, University of South Africa, Florida Campus, South Africa. Electronic address: .
Famuyide IM; Phytomedicine Programme, Department of Paraclinical Sciences, Faculty of Veterinary Science, University of Pretoria, Onderstepoort, South Africa. Electronic address: .
Elisha IL; Phytomedicine Group, Department of Pharmaceutical Sciences, Faculty of Science, Tshwane University of Technology, Private Bag X680 Arcadia, 0001, Pretoria, South Africa; Drug Development Section, Biochemistry Division, National Veterinary Research Institute, P.M.B. 01, Vom Plateau State, Nigeria. Electronic address: .
Kabongo-Kayoka PN; Department of Agriculture and Animal Health, Faculty of Agriculture and Environmental Sciences, University of South Africa, Florida Campus, South Africa. Electronic address: .
McGaw LJ; Phytomedicine Programme, Department of Paraclinical Sciences, Faculty of Veterinary Science, University of Pretoria, Onderstepoort, South Africa. Electronic address: .
Kahler-Venter CP; Department of Pharmacology and Therapeutics, School of Medicine, Sefako Makgatho University of Health Sciences, Ga-rankuwa, South Africa. Electronic address: .
Pokaż więcej
Źródło :
Journal of ethnopharmacology [J Ethnopharmacol] 2021 Mar 01; Vol. 267, pp. 113620. Date of Electronic Publication: 2020 Nov 25.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Asteraceae*/chemistry
Asteraceae*/classification
Asteraceae*/ultrastructure
Microscopy, Electron, Scanning*
Plant Leaves*/chemistry
Plant Leaves*/ultrastructure
Bronchodilator Agents/*pharmacology
Free Radical Scavengers/*pharmacology
Muscle Contraction/*drug effects
Neutrophils/*drug effects
Oxidative Stress/*drug effects
Plant Extracts/*pharmacology
Trachea/*drug effects
Adenosine Triphosphate/metabolism ; Animals ; Bronchodilator Agents/isolation & purification ; Free Radical Scavengers/isolation & purification ; Guinea Pigs ; Humans ; In Vitro Techniques ; Male ; Neutrophils/metabolism ; Plant Extracts/isolation & purification ; Superoxides/metabolism
Czasopismo naukowe
Tytuł :
Pharmacological management of human respiratory syncytial virus infection.
Autorzy :
Kalergis AM; Millennium Institute on Immunology and Immunotherapy, Departamento De Genética Molecular Y Microbiología, Facultad De Ciencias Biológicas, Pontificia Universidad Católica De Chile , Santiago, Chile.; Departamento De Endocrinología, Facultad De Medicina, Pontificia Universidad Católica De Chile , Santiago, Chile.
Soto JA; Millennium Institute on Immunology and Immunotherapy, Departamento De Genética Molecular Y Microbiología, Facultad De Ciencias Biológicas, Pontificia Universidad Católica De Chile , Santiago, Chile.
Gálvez NMS; Millennium Institute on Immunology and Immunotherapy, Departamento De Genética Molecular Y Microbiología, Facultad De Ciencias Biológicas, Pontificia Universidad Católica De Chile , Santiago, Chile.
Andrade CA; Millennium Institute on Immunology and Immunotherapy, Departamento De Genética Molecular Y Microbiología, Facultad De Ciencias Biológicas, Pontificia Universidad Católica De Chile , Santiago, Chile.
Fernandez A; Millennium Institute on Immunology and Immunotherapy, Departamento De Genética Molecular Y Microbiología, Facultad De Ciencias Biológicas, Pontificia Universidad Católica De Chile , Santiago, Chile.
Bohmwald K; Millennium Institute on Immunology and Immunotherapy, Departamento De Genética Molecular Y Microbiología, Facultad De Ciencias Biológicas, Pontificia Universidad Católica De Chile , Santiago, Chile.
Bueno SM; Millennium Institute on Immunology and Immunotherapy, Departamento De Genética Molecular Y Microbiología, Facultad De Ciencias Biológicas, Pontificia Universidad Católica De Chile , Santiago, Chile.
Pokaż więcej
Źródło :
Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2020 Dec; Vol. 21 (18), pp. 2293-2303. Date of Electronic Publication: 2020 Aug 18.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Respiratory Syncytial Virus Vaccines*
Adrenal Cortex Hormones/*therapeutic use
Antiviral Agents/*therapeutic use
Bronchodilator Agents/*therapeutic use
Respiratory Syncytial Virus Infections/*drug therapy
Respiratory Syncytial Virus, Human/*drug effects
Adrenal Cortex Hormones/administration & dosage ; Adrenal Cortex Hormones/adverse effects ; Antibodies, Monoclonal, Humanized/administration & dosage ; Antibodies, Monoclonal, Humanized/adverse effects ; Antibodies, Monoclonal, Humanized/therapeutic use ; Antiviral Agents/administration & dosage ; Antiviral Agents/adverse effects ; Bronchodilator Agents/administration & dosage ; Bronchodilator Agents/adverse effects ; Humans ; Palivizumab/administration & dosage ; Palivizumab/adverse effects ; Palivizumab/therapeutic use ; Respiratory Syncytial Virus Infections/immunology ; Respiratory Syncytial Virus Infections/prevention & control ; Respiratory Syncytial Virus Infections/virology ; Respiratory Syncytial Virus, Human/immunology ; Viral Proteins/antagonists & inhibitors ; Viral Proteins/immunology
Czasopismo naukowe
Tytuł :
Role of nebulized epinephrine in moderate bronchiolitis: a quasi-randomized trial.
Autorzy :
Yasin F; Department of Paediatric Medicine, University Hospital Kerry, Tralee, Ireland. .
Afridi ZS; Department of Paediatric Medicine, University Hospital Kerry, Tralee, Ireland.
Mahmood Q; Department of Paediatric Medicine, University Hospital Kerry, Tralee, Ireland.
Khan AA; Department of Paediatric Medicine, University Hospital Kerry, Tralee, Ireland.
Condon S; Department of Paediatric Medicine, University Hospital Kerry, Tralee, Ireland.
Khan RA; Department of Paediatric Medicine, University Hospital Kerry, Tralee, Ireland.
Pokaż więcej
Źródło :
Irish journal of medical science [Ir J Med Sci] 2021 Feb; Vol. 190 (1), pp. 239-242. Date of Electronic Publication: 2020 Jul 10.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Bronchiolitis/*drug therapy
Bronchodilator Agents/*therapeutic use
Epinephrine/*therapeutic use
Nebulizers and Vaporizers/*standards
Administration, Inhalation ; Bronchodilator Agents/pharmacology ; Child, Preschool ; Epinephrine/pharmacology ; Female ; Humans ; Infant ; Male
Czasopismo naukowe
Tytuł :
Tiotropium/Olodaterol Delays Clinically Important Deterioration Compared with Tiotropium Monotherapy in Patients with Early COPD: a Post Hoc Analysis of the TONADO Trials.
Autorzy :
Rabe KF; LungenClinic Grosshansdorf, Airway Research Center North, German Center for Lung Research (DZL), Grosshansdorf, Germany. .; Christian Albrechts University Kiel, Airway Research Center North, German Center for Lung Research (DZL), Kiel, Germany. .
Chalmers JD; Tayside Respiratory Research Group, University of Dundee, Dundee, UK.
Miravitlles M; Pneumology Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.; CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain.
Kocks JWH; General Practitioners Research Institute, Groningen, The Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Observational and Pragmatic Research Institute, Singapore, Singapore.
Tsiligianni I; Health Planning Unit, Department of Social Medicine, Faculty of Medicine, University of Crete, Crete, Greece.
de la Hoz A; Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.
Xue W; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA.
Singh D; Medicines Evaluation Unit (MEU), University of Manchester, Manchester University NHS Foundation Trust, Manchester, UK.
Ferguson GT; Pulmonary Research Institute of Southeast Michigan, Farmington Hills, MI, USA.
Wedzicha J; Respiratory Division, National Heart and Lung Institute, Imperial College London, London, UK.
Pokaż więcej
Źródło :
Advances in therapy [Adv Ther] 2021 Jan; Vol. 38 (1), pp. 579-593. Date of Electronic Publication: 2020 Nov 11.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Bronchodilator Agents*/therapeutic use
Pulmonary Disease, Chronic Obstructive*/drug therapy
Administration, Inhalation ; Adrenergic beta-2 Receptor Agonists/therapeutic use ; Benzoxazines/therapeutic use ; Drug Combinations ; Forced Expiratory Volume ; Humans ; Tiotropium Bromide/therapeutic use ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Magnesium sulphate for treating acute bronchiolitis in children up to two years of age.
Autorzy :
Chandelia S; Pediatric Emergency and Critical Care, PGIMER and Dr. RML Hospital, New Delhi, India.
Kumar D; Division of Pediatric Cardiology, Department of Pediatrics, PGIMER, Delhi, India.
Chadha N; PGIMER Library, PGIMER, Chandigarh, India.
Jaiswal N; ICMR Advanced Centre for Evidence-Based Child Health, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Pokaż więcej
Źródło :
The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2020 Dec 14; Vol. 12. Cochrane AN: CD012965. Date of Electronic Publication: 2020 Dec 14.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms :
Bronchiolitis/*drug therapy
Bronchodilator Agents/*therapeutic use
Magnesium Sulfate/*therapeutic use
Acute Disease ; Albuterol/therapeutic use ; Bias ; Bronchodilator Agents/administration & dosage ; Drug Therapy, Combination/methods ; Epinephrine/therapeutic use ; Humans ; Infant ; Infant, Newborn ; Length of Stay ; Magnesium Sulfate/administration & dosage ; Patient Readmission/statistics & numerical data ; Placebos/therapeutic use ; Randomized Controlled Trials as Topic ; Saline Solution/therapeutic use ; Severity of Illness Index
Czasopismo naukowe
Tytuł :
Dual- Versus Mono-Bronchodilator Therapy in Moderate to Severe COPD: A Meta-analysis.
Autorzy :
Lipari M; Wayne State University, Detroit, MI, USA.; Ascension St. John Hospital, Detroit, MI, USA.
Kale-Pradhan PB; Wayne State University, Detroit, MI, USA.; Ascension St. John Hospital, Detroit, MI, USA.
Wilhelm SM; Wayne State University, Detroit, MI, USA.
Pokaż więcej
Źródło :
The Annals of pharmacotherapy [Ann Pharmacother] 2020 Dec; Vol. 54 (12), pp. 1232-1242. Date of Electronic Publication: 2020 Jun 04.
Typ publikacji :
Journal Article; Meta-Analysis
MeSH Terms :
Adrenergic beta-2 Receptor Agonists/*administration & dosage
Bronchodilator Agents/*administration & dosage
Muscarinic Antagonists/*administration & dosage
Pulmonary Disease, Chronic Obstructive/*drug therapy
Administration, Inhalation ; Adrenergic beta-2 Receptor Agonists/therapeutic use ; Adult ; Bronchodilator Agents/therapeutic use ; Drug Therapy, Combination ; Forced Expiratory Volume ; Humans ; Middle Aged ; Muscarinic Antagonists/therapeutic use ; Prospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Comparison of two continuous nebulized albuterol doses in critically ill children with status asthmaticus.
Autorzy :
Lin AT; Department of Pediatrics, Section of Pediatric Critical Care, Nationwide Children's Hospital, The Ohio State University, Columbus, OH, USA.; Department of Anesthesia, Section of Palliative Care, Nationwide Children's, The Ohio State University, Columbus, OH, USA.
Moore-Clingenpeel M; Department of Pediatrics, Section of Pediatric Critical Care, Nationwide Children's Hospital, The Ohio State University, Columbus, OH, USA.; Biostatistics Resource at Nationwide Children's Hospital, Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.
Karsies TJ; Department of Pediatrics, Section of Pediatric Critical Care, Nationwide Children's Hospital, The Ohio State University, Columbus, OH, USA.
Pokaż więcej
Źródło :
The Journal of asthma : official journal of the Association for the Care of Asthma [J Asthma] 2020 Sep; Vol. 57 (9), pp. 980-986. Date of Electronic Publication: 2019 Jun 12.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Albuterol/*administration & dosage
Bronchodilator Agents/*administration & dosage
Critical Care/*methods
Resuscitation/*methods
Status Asthmaticus/*drug therapy
Administration, Inhalation ; Albuterol/adverse effects ; Bronchodilator Agents/adverse effects ; Child ; Child, Preschool ; Combined Modality Therapy/methods ; Combined Modality Therapy/statistics & numerical data ; Critical Care/statistics & numerical data ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Female ; Fluid Therapy/statistics & numerical data ; Humans ; Intensive Care Units, Pediatric/statistics & numerical data ; Length of Stay/statistics & numerical data ; Male ; Nebulizers and Vaporizers ; Prospective Studies ; Resuscitation/statistics & numerical data ; Retrospective Studies ; Status Asthmaticus/diagnosis
Czasopismo naukowe
Tytuł :
Large-volume, preservative-free albuterol concentrate.
Źródło :
The Medical letter on drugs and therapeutics [Med Lett Drugs Ther] 2020 Nov 02; Vol. 62 (1610), pp. 173-174.
Typ publikacji :
Journal Article
MeSH Terms :
Albuterol/*chemistry
Anti-Asthmatic Agents/*chemistry
Bronchodilator Agents/*chemistry
Preservatives, Pharmaceutical/*chemistry
Albuterol/therapeutic use ; Anti-Asthmatic Agents/therapeutic use ; Asthma/drug therapy ; Bronchodilator Agents/therapeutic use ; Humans
Czasopismo naukowe
Tytuł :
Identifying a nasal gene expression signature associated with hyperinflation and treatment response in severe COPD.
Autorzy :
Faiz A; Department of Pulmonology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB, Groningen, The Netherlands.; GRIAC (Groningen Research Institute for Asthma and COPD), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Department of Pathology & Medical Biology, Section Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Imkamp K; Department of Pulmonology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB, Groningen, The Netherlands. .; GRIAC (Groningen Research Institute for Asthma and COPD), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. .
van der Wiel E; Department of Pulmonology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB, Groningen, The Netherlands.; GRIAC (Groningen Research Institute for Asthma and COPD), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Boudewijn IM; Department of Pulmonology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB, Groningen, The Netherlands.; GRIAC (Groningen Research Institute for Asthma and COPD), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Koppelman GH; GRIAC (Groningen Research Institute for Asthma and COPD), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Department of Pediatric Pulmonology and Pediatric Allergology, Beatrix Children's Hospital, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Brandsma CA; GRIAC (Groningen Research Institute for Asthma and COPD), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Kerstjens HAM; Department of Pulmonology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB, Groningen, The Netherlands.; GRIAC (Groningen Research Institute for Asthma and COPD), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Timens W; GRIAC (Groningen Research Institute for Asthma and COPD), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Vroegop S; Department of Pulmonary Diseases, Martini Hospital Groningen, Groningen, The Netherlands.
Pasma HR; Department of Pulmonary Diseases, Medical Center Leeuwarden, Leeuwarden, The Netherlands.
Boersma WG; Department of Pulmonary Diseases, Medical Center Alkmaar, Alkmaar, The Netherlands.
Wielders P; Department of Pulmonary Diseases, Catharina Hospital Eindhoven, Eindhoven, The Netherlands.
van den Elshout F; Department of Pulmonary Diseases, Rijnstate Hospital, Arnhem, The Netherlands.
Mansour K; Department of Pulmonary Diseases, Orbis Concern, Sittard, The Netherlands.
Steiling K; Division of Computational Biomedicine, Department of Medicine, Boston University School of Medicine, Boston, MA, USA.
Spira A; Division of Computational Biomedicine, Department of Medicine, Boston University School of Medicine, Boston, MA, USA.
Lenburg ME; Division of Computational Biomedicine, Department of Medicine, Boston University School of Medicine, Boston, MA, USA.
Heijink IH; GRIAC (Groningen Research Institute for Asthma and COPD), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Department of Pathology & Medical Biology, Section Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Postma DS; Department of Pulmonology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB, Groningen, The Netherlands.; GRIAC (Groningen Research Institute for Asthma and COPD), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
van den Berge M; Department of Pulmonology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB, Groningen, The Netherlands.; GRIAC (Groningen Research Institute for Asthma and COPD), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2020 Oct 15; Vol. 10 (1), pp. 17415. Date of Electronic Publication: 2020 Oct 15.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Gene Expression Profiling*
Adrenergic beta-2 Receptor Agonists/*therapeutic use
Bronchodilator Agents/*therapeutic use
Budesonide/*therapeutic use
Formoterol Fumarate/*therapeutic use
Lung/*physiopathology
Nasal Cavity/*metabolism
Pulmonary Disease, Chronic Obstructive/*drug therapy
Pulmonary Disease, Chronic Obstructive/*genetics
Administration, Inhalation ; Aged ; Bronchodilator Agents/administration & dosage ; Budesonide/administration & dosage ; Case-Control Studies ; Dose-Response Relationship, Drug ; Female ; Formoterol Fumarate/administration & dosage ; Humans ; Male ; Middle Aged ; Placebos ; Pulmonary Disease, Chronic Obstructive/physiopathology
Czasopismo naukowe
Tytuł :
Training improves the handling of inhaler devices and reduces the severity of symptoms in geriatric patients suffering from chronic-obstructive pulmonary disease.
Autorzy :
Luley MC; Department of Geriatrics, Protestant Hospital Göttingen-Weende, An der Lutter 24, 37075, Göttingen, Germany.; Institute of Neuropathology, University Medical Center Göttingen, Göttingen, Germany.
Loleit T; Department of Geriatrics, Protestant Hospital Göttingen-Weende, An der Lutter 24, 37075, Göttingen, Germany.
Knopf E; Department of Geriatrics, Protestant Hospital Göttingen-Weende, An der Lutter 24, 37075, Göttingen, Germany.
Djukic M; Department of Geriatrics, Protestant Hospital Göttingen-Weende, An der Lutter 24, 37075, Göttingen, Germany.; Institute of Neuropathology, University Medical Center Göttingen, Göttingen, Germany.
Criée CP; Department of Pneumology, Protestant Hospital Göttingen-Weende, Göttingen, Germany.
Nau R; Department of Geriatrics, Protestant Hospital Göttingen-Weende, An der Lutter 24, 37075, Göttingen, Germany. .; Institute of Neuropathology, University Medical Center Göttingen, Göttingen, Germany. .
Pokaż więcej
Źródło :
BMC geriatrics [BMC Geriatr] 2020 Oct 09; Vol. 20 (1), pp. 398. Date of Electronic Publication: 2020 Oct 09.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Bronchodilator Agents*/therapeutic use
Pulmonary Disease, Chronic Obstructive*/diagnosis
Pulmonary Disease, Chronic Obstructive*/drug therapy
Aged ; Forced Expiratory Volume ; Humans ; Nebulizers and Vaporizers ; Prospective Studies
Czasopismo naukowe
Tytuł :
DuoResp adherence, satisfaction and ease of use: findings from a multi-country observational study in patients with asthma and COPD in Europe (SPRINT).
Autorzy :
van der Palen J; Department of Research Methodology, Measurement and Data Analysis, University of Twente, Enschede, The Netherlands.; Medical School Twente, Medisch Spectrum Twente, Enschede, The Netherlands.
Cerveri I; Unit of Respiratory Diseases, IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy.
Roche N; Cochin Hospital (APHP), Hôpitaux Universitaires Paris Centre, University Paris Descartes (EA2511), Paris, France.
Singh D; Centre for Respiratory Medicine and Allergy, University of Manchester, Manchester, UK.; The Medicines Evaluation Unit, University Hospital of South Manchester NHS Foundation Trust, Manchester, United Kingdom.
Plaza V; Department of Respiratory Medicine and Allergy, Hospital de la Santa Creu i Sant Pau, Institut d'Investigació Biomédica Sant Pau (IIB Sant Pau), Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
Gonzalez C; Unit of Statistics and Data Management, Experior SL, La Pobla de Farnals, Valencia, Spain.
Patino O; Teva Pharmaceuticals, Amsterdam, The Netherlands.
Scheepstra I; Teva Pharmaceuticals, Amsterdam, The Netherlands.
Safioti G; Teva Pharmaceuticals, Amsterdam, The Netherlands.
Backer V; Department of Respiratory Medicine, Bispebjerg University Hospital, Copenhagen University, Copenhagen, Denmark.
Pokaż więcej
Źródło :
The Journal of asthma : official journal of the Association for the Care of Asthma [J Asthma] 2020 Oct; Vol. 57 (10), pp. 1110-1118. Date of Electronic Publication: 2019 Jul 11.
Typ publikacji :
Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Patient Satisfaction*
Asthma/*drug therapy
Bronchodilator Agents/*therapeutic use
Budesonide, Formoterol Fumarate Drug Combination/*therapeutic use
Medication Adherence/*statistics & numerical data
Pulmonary Disease, Chronic Obstructive/*drug therapy
Administration, Inhalation ; Adult ; Aged ; Bronchodilator Agents/administration & dosage ; Budesonide, Formoterol Fumarate Drug Combination/administration & dosage ; Drug Combinations ; Dry Powder Inhalers ; Europe ; Female ; Humans ; Middle Aged ; Severity of Illness Index
Czasopismo naukowe
Tytuł :
Asthma control and quality of life in adolescents: The role of illness perceptions, medication beliefs, and adherence.
Autorzy :
Kosse RC; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, Utrecht, The Netherlands.
Koster ES; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, Utrecht, The Netherlands.
Kaptein AA; Medical Psychology, Leiden University Medical Center (LUMC), Leiden, The Netherlands.
de Vries TW; Department of Pediatrics, Medical Centre Leeuwarden (MCL), Leeuwarden, The Netherlands.
Bouvy ML; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, Utrecht, The Netherlands.
Pokaż więcej
Źródło :
The Journal of asthma : official journal of the Association for the Care of Asthma [J Asthma] 2020 Oct; Vol. 57 (10), pp. 1145-1154. Date of Electronic Publication: 2019 Jul 05.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Health Knowledge, Attitudes, Practice*
Asthma/*drug therapy
Asthma/*psychology
Bronchodilator Agents/*therapeutic use
Medication Adherence/*psychology
Quality of Life/*psychology
Adolescent ; Asthma/physiopathology ; Bronchodilator Agents/administration & dosage ; Child ; Cross-Sectional Studies ; Emotions ; Female ; Humans ; Male ; Perception
Czasopismo naukowe
Tytuł :
Tiotropium/Olodaterol Decreases Exacerbation Rates Compared with Tiotropium in a Range of Patients with COPD: Pooled Analysis of the TONADO Trials.
Autorzy :
Wedzicha JA; Respiratory Division, National Heart and Lung Institute, Imperial College London, London, UK. .
Buhl R; Johannes Gutenberg University Mainz, Mainz, Germany.
Singh D; Medicines Evaluation Unit, University of Manchester, Manchester University NHS Foundation Trust, Manchester, UK.
Vogelmeier CF; Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps University of Marburg, Member of the German Center for Lung Research (DZL), Marburg, Germany.
de la Hoz A; Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.
Xue W; Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA.
Anzueto A; Department of Pulmonary Medicine and Critical Care, University of Texas Health Sciences Center and South Texas Veterans Health Care System, San Antonio, TX, USA.
Calverley PMA; Clinical Science Centre, Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, UK.
Pokaż więcej
Źródło :
Advances in therapy [Adv Ther] 2020 Oct; Vol. 37 (10), pp. 4266-4279. Date of Electronic Publication: 2020 Aug 10.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Bronchodilator Agents*/therapeutic use
Pulmonary Disease, Chronic Obstructive*/drug therapy
Benzoxazines ; Double-Blind Method ; Humans ; Severity of Illness Index ; Tiotropium Bromide/therapeutic use
Czasopismo naukowe
Tytuł :
Efficacy of Tiotropium/Olodaterol Compared with Tiotropium as a First-Line Maintenance Treatment in Patients with COPD Who Are Naïve to LAMA, LABA and ICS: Pooled Analysis of Four Clinical Trials.
Autorzy :
Buhl R; Pulmonary Department, Johannes Gutenberg Universitat Mainz, Mainz, Germany. .
de la Hoz A; Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.
Xue W; Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA.
Singh D; Medicines Evaluation Unit, University of Manchester, Manchester University NHS Foundation Trust, Manchester, UK.
Ferguson GT; Pulmonary Research Institute of Southeast Michigan, Farmington Hills, MI, USA.
Pokaż więcej
Źródło :
Advances in therapy [Adv Ther] 2020 Oct; Vol. 37 (10), pp. 4175-4189. Date of Electronic Publication: 2020 Jul 15.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
MeSH Terms :
Bronchodilator Agents*/therapeutic use
Pulmonary Disease, Chronic Obstructive*/drug therapy
Adrenal Cortex Hormones/therapeutic use ; Adrenergic beta-2 Receptor Agonists/therapeutic use ; Benzoxazines/therapeutic use ; Drug Combinations ; Forced Expiratory Volume ; Humans ; Muscarinic Antagonists/therapeutic use ; Tiotropium Bromide/therapeutic use ; Treatment Outcome
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies